TUESDAY, June 24, 2024 (HealthDay News) -- Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women showed improved heart function after a year onsemaglutide, the active ingredient in Ozempic and Wegovy, researche...
Weight loss is strongly recommended in overweight and obese patients with coronary heart disease to improve blood pressure and lipids levels and reduce the risk of type 2 diabetes, thereby lowering the likelihood of another heart event. This study investigated the management of patients who were over...
The article discusses a research study which showed that weight loss failed to prevent heart attacks for patients with type II diabetes. Results showed the benefits of diet and exercise with respect to weight loss. Findings revealed an insignificant difference between weight loss and other strategies...
In heart failure (HF), weight loss (WL) has been associated with an adverse prognosis whereas obesity has been linked to lower mortality (the obesity paradox). The impact of WL in obese patients with HF is incompletely understood. Our objective was to explore the prevalence of WL and its ...
Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday. The injectable semaglutide — originally approved forweight lossfor certain patients — is now also indicated to reduce the risk of cardiovascular death, heart attack and stroke i...
The researchers noted further trials were needed to evaluate the impact of semaglutide on heart failure-related outcomes. As SELECT was not a dedicated heart failure trial, the study results cannot be extrapolated to patients with heart failure in general, they said. ...
These new weight loss medicines may be helpful in the treatment of several chronic medical conditions in obese individuals. There is no reason for those with psychiatric disorders to be excluded from such benefits. Carefully done, larger clinical trials are needed to underst...
A review of almost 20,000 patients who have had weight-loss surgery has revealed that the procedure also reduced several risk factors for cardiovascular disease and improved the structure and function of the heart. "Obesity is very bad for the heart," co-author Dr. Phil Schauer, director of...
Prescription diet drugs may be used as "second-line" treatment, when weight loss has not been successful and the patient has important health risks associated with being overweight or obese.Weight loss drugs are usually indicated for obese patients, or overweight patients with the presence of ...
Wegovy contains semaglutide, the same active ingredient found in Ozempic (that is approved for type 2 diabetes). Ozempic can lead to significant weight loss too, even though it's not approved for this use. In clinical studies, patients taking Wegovy (semaglutide) achieved an average weight loss...